Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05140642 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of AI LVEF
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 3,495
- Enrollment target
NCT05140642 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 3,495 participants.
The verdict
NCT05140642, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,495 participants
- Enrollment target
Study Summary
To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.
Interventions
- OTHER Automated annotation of the left ventricle through deep learning
- OTHER Sonographer Measurement of LVEF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,495 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05140642
The ClinicalTrials.gov registry entry for NCT05140642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,495 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Automated annotation of the left ventricle through deep learning is the first listed.
NCT05140642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05140642 about?
NCT05140642 is a clinical study titled "Safety and Efficacy Study of AI LVEF". To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in ...
What is the current status of trial NCT05140642?
This trial is currently completed. It is a NA study. The enrollment target is 3,495 participants. The study started on 2022-04-01. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT05140642?
The interventions under investigation include: Automated annotation of the left ventricle through deep learning (OTHER), Sonographer Measurement of LVEF (OTHER).
Who is sponsoring clinical trial NCT05140642?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.